<DOC>
	<DOCNO>NCT00489983</DOCNO>
	<brief_summary>This study elderly patient n't give prior chemotherapy patient treat platinum base chemotherapy . The patient eligible study diagnose advanced metastatic non-small cell lung cancer . The patient randomly assign one two treatment option : single agent pemetrexed single agent pemetrexed single agent gemcitabine follow right pemetrexed treatment .</brief_summary>
	<brief_title>Trial Pemetrexed Pemetrexed With Gemcitabine Patients With Advanced Lung Cancer Who Are Not Eligible Platinum-Based Chemotherapy Have Not Previously Been Treated With Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>histologically cytologically confirm NSCLC amenable surgery radiotherapy curative intent locally advance metastatic Stage IIIb ( N3 supraclavicular T4 pleural effusion ) IV NSCLC prior chemotherapy measurable disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) criterion ( Therasse et al . 2000 ) men woman great equal 70 year age patient , investigator â€™ opinion , eligible platinumbased chemotherapy receive treatment within last 30 day drug receive regulatory approval indication time study entry symptomatic brain metastasis history presence malignancy except situ carcinoma cervix adequately treat basal cell carcinoma skin prior malignancy treat 5 year without recurrence ( exclude melanoma , breast cancer hypernephroma ) unable interrupt therapy aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) naproxen , piroxicam , diflunisal , nabumetone around dose pemetrexed ( 5 day shortacting 8 day long act preparation ) unable unwilling take steroid unable unwilling take folic acid vitamin B12 supplementation clinically detectable ( physical examination ) thirdspace fluid collection ; example , ascites pleural effusion control drainage procedure prior study entry serious concomitant illness medical condition accord investigator criterion , include limited following : congestive heart failure angina pectoris , except medically control previous history myocardial infarction within 1 year study entry , uncontrolled hypertension , arrhythmias active infection require iv antibiotic active ulcer , unstable diabetes mellitus , contraindication corticotherapy superior vena cava syndrome</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>